Quick Answer
Virax Biolabs Group Ltd reported Research And Development Expense of $1.78 million for the year ending 2025.
- Virax Biolabs Group Ltd showed an increase of +13.9% in Research And Development Expense from 2024 to 2025.
- This data is from Virax Biolabs Group Ltd's annual report (Form 10-K), filed with the SEC on July 2, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Virax Biolabs Group Ltd's Research And Development Expense has grown by 1,380.4%.
- Historical annual values: Fiscal year 2025: $1.78 million | Fiscal year 2024: $1.56 million | Fiscal year 2023: $2.18 million | Fiscal year 2022: $433.7 thousand | Fiscal year 2021: $120.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: